Tango Therapeutics, Inc. (TNGX)
11.14
-0.26
(-2.28%)
USD |
NASDAQ |
Feb 27, 16:00
11.15
+0.01
(+0.09%)
After-Hours: 20:00
Tango Therapeutics Research and Development Expense (TTM) : 132.82M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| AbbVie, Inc. | 9.096B |
| Teleflex, Inc. | 180.89M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Amicus Therapeutics, Inc. | 135.84M |
| EyePoint Plc | 205.20M |